06/01/2026
Big news for Medicare Part D members đ
Starting July 1, 2026, a new pilot program called the Medicare GLP-1 Bridge may make certain weight loss medications more affordable for eligible beneficiaries.
Here are the highlights:
đˇ Covered medications currently include Wegovy, Zepbound (KwikPen formulation), and Foundayo
đˇ Eligible members would pay a flat $50 monthly copay, compared to typical retail prices that can exceed $1,000
đˇ Eligibility is based on BMI plus related health conditions
đˇ Prior authorization from a doctor is required
đˇ The program runs through December 31, 2027
This is one of the most significant Medicare drug coverage changes in years. If you've ever wondered whether GLP-1 medications might fit your health picture, this is worth a closer look.